Sucralfate can help with acid reflux symptoms, but it is not considered an effective standalone treatment for gastroesophageal reflux disease (GERD). The American College of Gastroenterology specifically recommends against using sucralfate for GERD therapy, with one notable exception: pregnancy. For most people with ongoing reflux, acid-suppressing medications remain far more effective.
How Sucralfate Works
Sucralfate takes a completely different approach than the medications most commonly used for acid reflux. Instead of reducing acid production, it forms a physical barrier over damaged tissue. When you swallow it, the medication breaks apart in your stomach’s acidic environment and binds to proteins on both normal and injured tissue, creating a thick, paste-like coating. This gel shields the lining of your digestive tract from stomach acid and pepsin, the enzyme that breaks down proteins and can erode tissue.
Beyond simply acting as a shield, sucralfate stimulates your body’s own protective mechanisms. It increases mucus production and makes that mucus thicker and more resistant to being dissolved by digestive enzymes. A single gram of sucralfate can also neutralize a small amount of acid directly, though this effect is modest compared to dedicated acid-reducing drugs.
This coating action is why sucralfate works well for ulcers, where there’s a defined wound in the stomach lining that needs protection to heal. The esophagus, however, presents a different challenge. Reflux exposes a long stretch of tissue to acid repeatedly, and a protective coating may not adhere as reliably to esophageal tissue, especially when new waves of acid wash over it.
What the Evidence Actually Shows
Sucralfate is FDA-approved for one condition: short-term treatment of active duodenal ulcers (up to 8 weeks). Its use for acid reflux is off-label, and the clinical data supporting it for GERD is thin. Limited studies have suggested it may work about as well as older acid-blocking medications called H2 receptor antagonists, but there are no head-to-head comparisons with proton pump inhibitors (PPIs), which are the current standard treatment for reflux.
The ACG’s 2022 clinical guideline puts it bluntly: “There is little to recommend for this agent in GERD outside of pregnancy.” A narrative review in Translational Gastroenterology and Hepatology reached a similar conclusion, noting that data supporting sucralfate’s effectiveness in GERD, particularly for erosive esophagitis (visible damage to the esophagus), is “very limited” and that its routine use “is not recommended.” Even combining sucralfate with a PPI hasn’t been shown to meaningfully improve healing or symptom control beyond what a PPI achieves alone.
One small study did find a potential benefit: adding sucralfate to high-dose PPI therapy may help prevent strictures (scar tissue narrowing) in patients with severe erosive esophagitis. But with only 15 patients total, this finding is preliminary at best.
The Pregnancy Exception
Sucralfate occupies a unique niche for pregnant people dealing with reflux. Because the medication is barely absorbed into the bloodstream, it carries essentially no systemic toxicity. This makes it one of the safer options during pregnancy, when many standard reflux medications raise concerns. Professional guidelines on treating reflux during pregnancy and lactation specifically include sucralfate as an acceptable choice, alongside alginate-based products. During breastfeeding, medications with minimal systemic absorption like sucralfate are similarly preferred, though formal safety data during lactation is limited.
Side Effects and Safety Concerns
For most people, sucralfate is well tolerated. Constipation is the most common side effect, occurring in about 2% of users. Other reported issues are uncommon and generally mild.
The more serious concern involves kidney function. Sucralfate contains aluminum, which healthy kidneys filter out without trouble. If you have chronic kidney disease or are on dialysis, however, your body can’t clear aluminum efficiently, and dialysis membranes don’t remove it because it binds to blood proteins. Over time, aluminum can accumulate and cause bone disease or neurological problems. People with impaired kidney function need to be cautious with sucralfate for this reason.
Timing and Drug Interactions
Sucralfate is unusually demanding when it comes to scheduling. You need to take it on an empty stomach, either one hour before or two hours after eating. If you take antacids, they should be separated from sucralfate by at least 30 minutes. The sticky, binding quality that makes sucralfate effective at coating tissue also means it can latch onto other medications in your stomach, reducing how much of those drugs your body absorbs. This is a particular concern with thyroid medications, certain antibiotics, heart medications, and many other common prescriptions. If you take multiple medications, the timing logistics alone can make sucralfate impractical.
Liquid vs. Tablet Form
Sucralfate comes as both a liquid suspension and a tablet. For acid reflux specifically, there’s a logical argument that the liquid form would work better. Since sucralfate’s benefit depends on physically coating tissue, a suspension that’s already in liquid form should contact the esophagus more directly than a tablet that first needs to dissolve in the stomach. A gel formulation could theoretically be even better, since it might cling to esophageal tissue longer. However, this reasoning hasn’t been validated by strong clinical evidence. The perception that formulation determines effectiveness is widespread, but the data hasn’t caught up to confirm it.
Where Sucralfate Fits In
If you’re dealing with occasional reflux and can’t take or prefer to avoid acid-suppressing medications, sucralfate might offer some symptomatic relief by protecting irritated tissue. It’s a reasonable option during pregnancy when choices are limited. But for most people with regular acid reflux or diagnosed GERD, sucralfate simply doesn’t perform at the level of PPIs or even H2 blockers. The evidence isn’t there to support it as a primary treatment, and professional guidelines reflect that gap clearly.